Articles
52
All (52)
SCI-E, SSCI, AHCI (34)
SCI-E, SSCI, AHCI, ESCI (45)
ESCI (11)
Scopus (39)
TRDizin (9)
Other Publications (2)
4. A Large Room for Improvement Concerning the Management of Relapsed Refractory Large B-cell Lymphoma in Türkiye: Real-World Outcomes in the Setting Without Access to T-Cell Redirecting Therapies.
Turkish journal of haematology : official journal of Turkish Society of Haematology
, 2025 (SCI-Expanded, Scopus, TRDizin)
11. Can BATF Expression Serve as a Predictive Marker for Treatment Necessity in Chronic Lymphocytic Leukemia?
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, vol.35, no.3, pp.193-201, 2025 (SCI-Expanded, Scopus, TRDizin)
14. Identification of HLA alleles involved in immune thrombotic thrombocytopenic purpura patients from Turkey.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
, vol.35, no.6, pp.307-315, 2024 (SCI-Expanded, Scopus)
20. Independent risk factors for COVID-19-associated coagulopathy
European Review for Medical and Pharmacological Sciences
, vol.27, no.16, pp.7851-7860, 2023 (SCI-Expanded, Scopus)
21. Salvage Intrapartum Splenectomy for the Treatment of Transfusion-refractory Anaemia in a ß-thalassemia Intermedia Patient.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
, vol.32, no.10, pp.1344-1346, 2022 (SCI-Expanded, Scopus)
27. Raman tweezers as an alternative diagnostic tool for paroxysmal nocturnal hemoglobinuria.
Analytical methods : advancing methods and applications
, vol.13, no.35, pp.3963-3969, 2021 (SCI-Expanded, Scopus)
29. R-CHOP Chemotherapy with a Rituximab Biosimilar (Redditux®) for Patients with de novo Diffuse Large B-cell Lymphoma: First Preliminary Results of a Real-Life Single-Center Experience from Turkey
Özbalak M. M., Mastanzade M., Özlük Ö., Tiryaki T. O., Pınar Özbalak E., Yönal Hindilerden İ., et al.
İstanbul Kanuni Sultan Süleyman Tıp Dergisi
, vol.13, no.3, pp.194-198, 2021 (TRDizin)
30. KILLER IMMUNOGLOBULINE LIKE RECEPTOR GENE ANALYSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND ITS RELATION WITH AUTOIMMUNITY
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
, vol.84, no.2, pp.227-236, 2021 (ESCI, TRDizin)
41. Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.
Annals of oncology : official journal of the European Society for Medical Oncology
, vol.28, no.10, pp.2496-2502, 2017 (SCI-Expanded, Scopus)
51. Prognostic significance of micro vessel density in diffuse large B cell lymphomas
VIRCHOWS ARCHIV
, vol.451, no.2, pp.357-358, 2007 (SCI-Expanded, Scopus)
52. Primary cutaneous T-cell lymphomas other than mycosis fungoides and primary cutaneous CD30(+) lymphoproliferative disorders
VIRCHOWS ARCHIV
, vol.451, no.2, pp.456, 2007 (SCI-Expanded, Scopus)
Papers Presented at Peer-Reviewed Scientific Conferences
36
1. Nüks Etmiş veya Dirençli Büyük B-Hücreli Lenfomanın Tedavisinde Karşılanmamış İhtiyaçlar: Bispesifik ve CAR-T Erişimi Olmayan Çok Merkezli 1369 Hasta Kohortunda İkinci Sıra Tedavilerinin İncelenmesi
51. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 28 October 2025, pp.94-95, (Summary Text)
5. A Single-Center Real-Life Experience with First-Line Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone (DARA-VCD) in AL Amyloidosis
MASTANZADE M., ÖREN ÇELİK M. M., ERDEM S., ÖZBALAK M. M., YÖNAL HİNDİLERDEN İ., YENEREL M. N., et al.
Hematoloji Uzmanlık Derneği 18. Ulusal Kongresi, Antalya, Turkey, 21 - 24 November 2024, vol.46, pp.26-27, (Summary Text)
6. Akut Miyeloid Lösemide İzositrat Dehidrogenaz 1 (IDH1) Gen Mutasyonu Sıklığı ve Klinik: Tek Merkez Deneyimi
50. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 29 October 2024, pp.228, (Summary Text)
7. AL Amiloidozda Karaciğer Tutulumunun Sessiz İzleri: Fibroscan Yol Gösterir mi?
50. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 29 October 2024, pp.185, (Summary Text)
9. Kronik lenfositer lösemi olgularının tanı sırasındaki T lenfosit alt gruplarının prognoz üzerine etkisi
48. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 01 November 2022, pp.145-146, (Summary Text)
10. Büyük granüllü lenfosit artışı olan olguların tanısında immünfenotiplemenin rolü: Tek merkez deneyimi
48. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 01 November 2022, pp.199-200, (Summary Text)
11. Multipl miyelom dışı plazma hücre hastalıklarında kök hücre desteği ile yüksek doz kemoterapi deneyimi
48. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 01 November 2022, pp.196-197, (Summary Text)
12. Red cell alloimmunization in multi-transfused Turkish patients with hematologic disorders
EHA 2022 Hybrid Congress, Vienna, Austria, 9 - 17 June 2022, pp.2844, (Summary Text)
18. R-CHOP Chemotherapy Including Biosimilar Rituximab (Redditux) for De-Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single Center Experience
63rd ASH Annual Meeting and Exposition, Georgia, United States Of America, 11 - 14 December 2021, pp.4585, (Summary Text)
20. Increased activity of follicular helper T and cytotoxic T cellsin chronic lymphocytic leukemia
6th European Congress of Immunology (ECI 2021), Belgrade, Serbia, 1 September - 04 October 2021, pp.1, (Summary Text)
21. Increased activity of follicular helper T and follicular cytotoxic T cells in Chronic Lymphocytic Leukemia
6th European Congress of Immunology, Belgrade, Serbia, 1 - 04 September 2021, pp.245, (Summary Text)
24. BAŞVURU ANI TAM KAN SAYIMI PUANLAMASININ COVID-19 HASTALARINDA İLERLEYİCİ HASTALIĞI GÖSTERMEDE ROLÜ
46. Ulusal Hematoloji Kongresi, Turkey, 28 - 31 October 2020, (Summary Text)
27. Dipyridamole Added to Anticoagulant Prophylaxis: Decline in Poor Outcome of Clinically Severe Ill COVID-2019 Patients
International Society on Thrombosis and Hemostasis Annual Congress 2020, 12 - 14 July 2020, (Summary Text)
28. A relapsed refractory CD30 positive cutaneous anaplastic large cell lymphoma with large B-cell transformation responding to brentuximab vedotin after multiple lines of treatment.
Xth International Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, pp.560, (Summary Text)
32. Role of [68Ga]-pentixafor-PET/CT as a novel imaging of cxcr4 expression in multiple myeloma comparison to [18F]-FDG-PET/CT
Xth International Eurasian Hematology-Oncology Congress, İstanbul, Turkey, 8 - 12 October 2019, vol.85, (Summary Text)
Metrics